VECTUS BIOSYSTEMS LIMITED - Corporate Spotlight

Market Cap $4.256M Add to my watchlist

Vectus Biosystems Limited is an Australia-based drug discovery and development company.... Vectus Biosystems Limited is an Australia-based drug discovery and development company. The Company focuses on medical research and development. It is engaged in developing a treatment for fibrosis and high blood pressure, which includes the treatment for diseases in the fibrotic market, namely heart, kidney, and liver diseases. Its compound, VB0004, focuses on treating the hardening of functional tissue and high blood pressure. It also focuses on developing candidates for the treatment of fibrotic liver diseases, including non-alcoholic steatohepatitis (NASH) as well as pulmonary fibrotic diseases. The Company has also developed technology focused at improving the speed and accuracy of measuring the amount of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in samples tested in laboratories. Accugen is a platform, developed by its wholly owned subsidiary, Accugen Pty Limited, comprising of reagents, and software that quantitate polymerase chain reaction (qPCR) reactions.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

No Corporate Spotlight currently available.

(20min delay)
Last 8.0¢		Change 0.000(0.00%)		Mkt cap ! $4.256M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
1	68000	7.8¢

Sellers (Offers)

Price($)	Vol.	No.
11.5¢	6250	1

View Market Depth

No.	Vol.	Price($)
1	13462	0.076
1	40000	0.075
1	40000	0.072
1	85000	0.070
1	15166	0.065

Price($)	Vol.	No.
0.080	114426	1
0.000	0	0
0.000	0	0
0.000	0	0
0.000	0	0

Last trade - 16.12pm 21/11/2024 (20 minute delay)

VBS (ASX) Chart

Day chart unavailable